Metabolic characteristics of programmed cell death‐ligand 1‐expressing lung cancer on (18)F‐fluorodeoxyglucose positron emission tomography/computed tomography

Programmed cell death‐1 (PD‐1) and programmed cell death‐ligand 1 (PD‐L1) have been identified as novel targets of immunotherapy of lung cancer. In present study, we evaluated the metabolic characteristics of lung cancer by using (18)F‐fluorodeoxyglucose positron emission tomography/computed tomogra...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Cancer Med
Egile Nagusiak: Takada, Kazuki, Toyokawa, Gouji, Okamoto, Tatsuro, Baba, Shingo, Kozuma, Yuka, Matsubara, Taichi, Haratake, Naoki, Akamine, Takaki, Takamori, Shinkichi, Katsura, Masakazu, Shoji, Fumihiro, Honda, Hiroshi, Oda, Yoshinao, Maehara, Yoshihiko
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: John Wiley and Sons Inc. 2017
Gaiak:
Clinical Cancer Research
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5673920/
https://ncbi.nlm.nih.gov/pubmed/28980429
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cam4.1215
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak